Related Experiment Video
Updated: Aug 10, 2025
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Preclinical models in head and neck squamous cell carcinoma
Patricia Chaves1, María Garrido1, Javier Oliver1
1Medical Oncology Service (Group of Translational Research in Cancer Immunotherapy), Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma Bionand, C/Marqués de Beccaría n°3, 29010, Málaga, Spain.
Developing reliable preclinical models is crucial for advancing head and neck cancer research. This review examines current models and future directions for personalized therapies in head and neck squamous cell carcinoma.
Area of Science:
- Oncology
- Cancer Research
- Preclinical Modeling
Background:
- Head and neck cancer is a significant global health concern, ranking as the sixth most common cancer.
- Existing therapies for head and neck squamous cell carcinoma (HNSCC) face challenges including drug resistance and toxicity.
- Reliable preclinical models are essential for understanding HNSCC's molecular mechanisms and improving treatment outcomes.
Purpose of the Study:
- To review and critically evaluate established and emerging preclinical models for head and neck squamous cell carcinoma.
- To assess the efficacy of current models in replicating the molecular and cellular complexity of HNSCC.
- To discuss future opportunities and challenges in preclinical model development for personalized HNSCC therapies.
Main Methods:
- Review of literature on traditional and advanced preclinical models for HNSCC.
- Analysis of cell-based models including immortalized cell lines, primary tumor cultures (monolayer and 3D).
- Evaluation of animal models currently utilized in HNSCC research.
Main Results:
- Traditional models like cell lines and murine models have limitations in fully recapitulating HNSCC complexity.
- 3D cultures and advanced animal models show promise in better mimicking the tumor microenvironment.
- Significant discrepancies exist between preclinical model performance and clinical outcomes.
Conclusions:
- Current preclinical models offer valuable insights but require further refinement to enhance translational relevance for HNSCC.
- Future research should focus on developing more sophisticated models that capture the heterogeneity of HNSCC.
- Advanced preclinical models hold significant potential for advancing personalized medicine approaches in head and neck cancer treatment.
